|
|
Psoriatic Arthritis
|
|
Psoriatic Arthritis
[an error occurred while processing this directive]
Patients With Active Psoriatic Arthritis Receiving REMICADE(R) ... Nov 16, 2005
New data, including two-year treatment duration, show a significantly higher proportion of patients with active psoriatic arthritis receiving REMICADE(R ...
- PR Newswire (press release),
Study: J&J’s Remicade is Useful Against Psoriatic Arthritis Nov 16, 2005
Johnson & Johnson's Centocor unit announced today that two-year data from studies of its drug Remicade in psoriatic arthritis, in which swollen joints ...
- Business New Jersey (subscription),
Veelbelovende AMEVIVE fase II 'psoriatic arthritis' data ... Nov 15, 2005
...( BW)(CA-BIOGEN-IDEC)(BIIB) Promising AMEVIVE(R) (alefacept) Phase II Psoriatic Arthritis Data Presented at American College of Rheumatology Meeting ...
- Netherlands Corporate News,
Promising Amevive® (Alefacept) Phase Ii Psoriatic Arthritis Data ... Nov 15, 2005
Phase II study, presented at the annual meeting of the American College of Rheumatology (ACR), show that patients with active psoriatic arthritis who received ...
- WebWire (press release),
Study: Remicade eases arthritis pain Nov 17, 2005
New data, including two-year treatment duration, show a significantly higher proportion of patients with active psoriatic arthritis receiving Remicade ...
- myDNA.com,
Treatment has demonstrated improvement in physical function and ... Nov 20, 2005
...the signs and symptoms, inhibit the progression of structural damage of active arthritis, and improve physical function in patients with psoriatic arthritis. ...
- Medical News Today (press release),
Combination Therapy With ENBREL And Methotrexate Found Effective ... Nov 21, 2005
People with different forms of arthritis such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis have elevated levels of TNF ...
- MedIndia,
Abbott's ATLAS Study Shows Significant Reduction in Signs and ... Nov 13, 2005
ATLAS are extremely encouraging and help to reaffirm the potential of HUMIRA, having shown efficacy in rheumatoid arthritis and psoriatic arthritis and now ...
- PR Newswire (press release),
FDA Accepts Application Requesting Approval of REMICADE(R) in the ... Nov 7, 2005
In May 2005 the FDA approved REMICADE for reducing signs and symptoms of active arthritis in patients with psoriatic arthritis. ...
- Yahoo! News (press release)
Centocor and Schering-Plough Next-Generation Biologic Shows ... Nov 16, 2005
Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and ulcerative ...
- PR Newswire (press release),
Biogen Idec reports Amevive helps with arthritis Nov 15, 2005
The Cambridge, Mass., company (Nasdaq: BIIB) said on Tuesday that Amevive helped patients with psoriatic arthritis achieve significant improvement and the drug ...
- Boston Business Journal,
HUMIRA(R) (Adalimumab) Shows Promise in Treating Patients With ... Nov 13, 2005
The safety profile for patients with psoriatic arthritis treated with HUMIRA in the clinical trials has been similar to the safety profile seen in patients ...
- PR Newswire (press release),
(PRN) - SAP Presentation at Investor Conference in Barcelona ... ... Nov 16, 2005
...[+]. (PRN) - Patients With Active Psoriatic Arthritis Receiving REMICADE(R) Therapy Achieve 'Major Clinical Response' in Arthritic Component of Disease ... [+. ...
- Bolsamania.com,
Genetic link between heart disease and psoriasis Oct 29, 2005
...more targeted forms of diagnosis and treatment for the 125 million people around the globe who live with the misery of psoriasis and psoriatic arthritis. ...
- Medical News Today (press release),
REMICADE Data Show Promise for Children Afflicted With Crohn's ... Oct 25, 2005
...factor alpha (TNF-alpha) therapies and has demonstrated broad clinical utility in CD, rheumatoid arthritis (RA), psoriatic arthritis, ulcerative colitis and ...
- Market Wire (press release)
Treatment Has Demonstrated Improvement in Physical Function and ... Nov 13, 2005
...important role in bothnormal immune function and the cascade of reactions involved in theinflammatory process of RA, JRA, psoriasis, psoriatic arthritis, andAS ...
- Finanzen.net,
Abbott's HUMIRA(R) (Adalimumab) Shows Promising Results in Long ... Oct 31, 2005
..."HUMIRA was developed as a treatment for rheumatoid arthritis and was recently approved for psoriatic arthritis," said Peter Isakson, Ph.D. and divisional vice ...
- Finanzen.net,
Biogen data suggest drug helps joints Nov 15, 2005
...of the study. It showed hat its Amevive drug significantly improved the signs of symptoms of psoriatic arthritis. Biogen now says ...
- Providence Eyewitness News,
Doctor is moderator at conference Oct 24, 2005
FREDERICK, Md. - Dr. Nathan Wei served as the expert moderator at a recent conference entitled "Summit on Psoriatic Arthritis." The meeting was held Sept. ...
- Hagerstown Morning Herald,
Artist grows increasingly ill in test Nov 7, 2005
He took the medication methotrexate to control psoriasis and a mild case of psoriatic arthritis, a condition causing inflammation of the skin and joints. ...
- Seattle Times,
Grants to fund research on preparing for bioterrorist attack Nov 12, 2005
..."Along with RA, anti-TNF drugs are now used to treat psoriasis, psoriatic arthritis and Crohn's disease and our studies, therefore, apply to a growing sector ...
- Medical News Today (press release),
Understand The Symptoms Nov 15, 2005
In patients 20-50 years old, inflammatory conditions such as ankylosing spondylitis, psoriatic arthritis, Reiters syndrome, and inflammatory bowel disease are ...
- 50 Connect,
Schering-Plough Reports 2005 Third Quarter Financial Results Oct 24, 2005
...the United States (excluding Japan and certain Far East markets) for rheumatoid arthritis, early rheumatoid arthritis, psoriatic arthritis, Crohn's disease ...
- PR Newswire (press release),
CAT, Abbott Settle Humira Dispute: Abbot Pays $255M Oct 26, 2005
...throughout the US and Europe, and recently gained approval as a first-line treatment of moderate to severe early rheumatoid arthritis and psoriatic arthritis. ...
- BioWorld Online (subscription),
Frost & Sullivan Honors Companies With Best Practices Awards Nov 15, 2005
2005 Medical Devices Emerging Leader of the Year Award Centocor, Inc. -- 2005 Psoriasis and Psoriatic Arthritis Product Differentiation Innovation of the ...
- Yahoo! News (press release)
Multi-million dollar deal to benefit medical research Oct 29, 2005
...trials for use in other indications including Phase III trials for use in juvenile rheumatoid arthritis, Crohn's disease, psoriatic arthritis and ankylosing ...
- Medical News Today (press release),
Targeted Genetics Presents Additional Data from Its Inflammatory ... Oct 31, 2005
...to enrollup to 40 subjects and will evaluate tgAAC94 at two dose levels inpatients with rheumatoid arthritis, psoriatic arthritis or ankylosingspondylitis and ...
- Finanzen.net,
Schering-Plough Highlights R&D Pipeline and Product Portfolio at ... Nov 1, 2005
...medicine is also used to treat a wide range of immune- mediated inflammatory disorders, including Crohn's disease, psoriatic arthritis, rheumatoid arthritis ...
- Yahoo! News (press release)
Targeted Genetics Presents Additional Data from Its Inflammatory ... Oct 31, 2005
...is designed to enroll up to 40 subjects and will evaluate tgAAC94 at two dose levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing ...
- Genetic Engineering News,
Abbott settles dispute over royalties on Humira for $300 million ... Oct 27, 2005
1. Humira, which also is approved to treat psoriatic arthritis, is expected to generate more than $1.3 billion in sales for Abbott this year. ...
- Chicago Sun-Times,
J&J Unit Says FDA Accepts Remicade App Nov 7, 2005
The drug is already approved to treat a number of inflammatory conditions, including rheumatoid arthritis and psoriatic arthritis, or joint inflammation ...
- MSN Money
UPDATE 1-Abbott's Humira promising for Crohn's Disease Oct 31, 2005
Humira, which was recently approved to treat psoriatic arthritis, is Abbott's biggest product with global sales of $356 million during the third quarter. ...
- Reuters
ABBOTT: Pharmaceutical Products Group Highlights Oct 24, 2005
...regulatory approval to market HUMIRA(R) (adalimumab) for the first-line treatment of moderate to severe early rheumatoid arthritis (RA) and psoriatic arthritis ...
- Webbolt Business News (subscription),
An acid-sensing cellular receptor might have clinical relevance in ... Oct 27, 2005
...primary cultures of human synovial cells from patients with inflammatory arthropathies, such as rheumatoid arthritis and psoriatic arthritis." The researchers ...
- Xagena.it,
Role in arthritis drug nets Scripps $34 million Nov 4, 2005
...people suffering from chronic conditions like rheumatoid arthritis, and it also just got approval for people suffering from psoriatic arthritis," Smoter said. ...
- Palm Beach Post,
Cambridge Antibody Technology Acquires Oncology Product Candidates ... Oct 31, 2005
...with Abbott and has been approved for marketing as a treatment for rheumatoid arthritis (RA) in 57 countries, and for psoriatic arthritis and early RA in some ...
- Yahoo! News (press release)
Abbott to pay $300M to settle Humira fight Oct 27, 2005
Humira, which also is approved to treat psoriatic arthritis, is expected to bring Abbott sales of more than $1.3 billion in sales this year.
- United Press International
Business briefs Nov 2, 2005
...tract. Humira, which is made in Worcester by Abbott Bioresearch Center, is approved for rheumatoid arthritis and psoriatic arthritis. ...
- Worcester Telegram (subscription),
Drug Industry Human Testing Masks Death, Injury, Compliant FDA ... Nov 1, 2005
Hamlet says the medication he was taking before the test, methotrexate, successfully controlled his psoriatic arthritis, a condition causing inflammation of ...
- Bloomberg
Health Briefs: Nov. 1, 2005 Oct 31, 2005
Dr. Eric Hochman, a rheumatologist at Anchor Health Centers in Naples, will speak about rheumatoid and psoriatic arthritis from 11:30 am-1:30 pm Friday at ...
- Naples Daily News (subscription),
Iverson Sponsors Run/Walk for Psoriatic Arthritis: Area Businesses ... Sep 22, 2005
...was one of several sponsors of the second annual Michael Tarney Run/Walk for Psoriatic Arthritis, which was held on September 10th in Milwaukee, Wisconsin. ...
- PR Web (press release)
The road to awareness Oct 2, 2005
Dan is a very unique individual and he's definitely a giver," Muth said. Muth, now 40, first learned he had psoriatic arthritis when he was 23. ...
- Daily Breeze
Ascentia Biomedical Corporation Announces the Addition of Dr. ... Sep 30, 2005
...has been the principal investigator for over 75 clinical studies involving drugs for indications such as rheumatoid arthritis, psoriatic arthritis and psoriasis ...
- PR Newswire (press release)
Four times longer to get arthritis help in west, says campaigner Sep 29, 2005
...at Merlin Park Hospital, who will speak about current treatments and the use of new biologic drugs in treating rheumatoid and psoriatic arthritis at 2pm. ...
- Galway Advertiser
COMPANY OF THE YEAR: Johnson & Johnson Sep 15, 2005
FDA approved the drug to reduce the signs and symptoms of active arthritis in patients with psoriatic arthritis. An immune-mediated ...
- Med Ad News (subscription)
FDA Approves Remicade(R) as First and Only Biologic to Treat ... Sep 16, 2005
In addition to UC and CD, REMICADE is also indicated for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. ...
- Market Wire (press release)
Cambridge Antibody Technology Announces Financial Results for the ... Sep 11, 2005
In August 2005, Abbott announced that it had received approval from the European Commission to market HUMIRA as a treatment for psoriatic arthritis and early ...
- PR Newswire (press release)
Psoriasis Advocacy Group Urges FDA Panel to Approve Abatacept for ... Sep 6, 2005
...seen repeatedly in the past, many of the same medications that help RA patients also bring relief to people with psoriasis or psoriatic arthritis, and vice ...
- U.S. Newswire (press release)
First true animal model for psoriasis Sep 20, 2005
...psoriasis. Whereas previous models were only able to reproduce the skin lesions, the new strain also develops psoriatic arthritis. ...
- News-Medical.net
Deborah Hobson stands in front of her handicap-accessible Habitat ... Sep 27, 2005
Hobson is afflicted with psoriatic arthritis, raynoids blood phenomenon and scoliosis. Her daughters Katherine, 8, and Victoria, 5, have cerebral palsy. ...
- Jupiter Courier (subscription)
FDA Approves Ulcerative Colitis Treatment Sep 18, 2005
...their colons.". Remicade is also indicated for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
- All Headline News
FDA Approvals: Remicade, Neulasta, NovoLog Sep 22, 2005
...those observed in trials for previously approved indications, including rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, and psoriatic arthritis. ...
- Medscape (subscription)
Business news in brief Sep 17, 2005
Remicade is already approved by the FDA for treating rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Chrohn's disease. ...
- Philadelphia Inquirer
FDA approves J&J's ulcerative colitis drug Sep 16, 2005
FDA. Remicade is also approved to treat rheumatoid arthritis, Crohn's disease, ankylosing spondylitis and psoriatic arthritis. The ...
- MarketWatch
Abbott faces a new rival in arthritis treatments Sep 8, 2005
Enbrel, Remicade and Humira anytime soon because those drugs are further along in studies for other uses such as psoriasis, psoriatic arthritis and Crohn's ...
- Chicago Tribune
Centocor gets ulcerative colitis FDA OK Sep 16, 2005
Remicade is already approved for rheumatoid arthritis, where the immune system attacks the joints; psoriatic arthritis, or arthritis accompanied by scaly skin ...
- BusinessWeek
FDA panel OKs Bristol arthritis drug Sep 6, 2005
..."This is good news for rheumatoid-arthritis patients, and also those with psoriasis and psoriatic arthritis, because the drug may also prove beneficial to ...
- Newark Star Ledger
Wyeth Opens World's Largest Integrated Biotech Production Facility Sep 7, 2005
...markets around the world and can be used to treat rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriasis and psoriatic arthritis ...
- PR Newswire (press release)
Amgen Announces FDA Licensure of Two New Manufacturing Facilities ... Sep 6, 2005
...the company's leading inflammation biologic used in the treatment of diseases such as moderate to severe rheumatoid arthritis, psoriatic arthritis and moderate ...
- Business Wire (press release)
Inside story: misdiagnosis: a long path to health Sep 2, 2005
But by the time a rheumatology consultant finally told me seven years later that I had psoriatic arthritis (no, I’d never heard of it either, but it affects ...
- Times Online
Remicade Cleared for Added Use Sep 16, 2005
...indication. The multifaceted drug is already approved in the US for treating rheumatoid arthritis and psoriatic arthritis. Remicade ...
- TheStreet.com
A neglected disease till patient's girl took charge Sep 21, 2005
...debilitating. It can degenerate into psoriatic arthritis, a painful inflammation that, left untreated, can deform joints and limbs. ...
- Newark Star Ledger
NEWS RELEASE Sep 7, 2005
...factory in West Greenwich, RI, will make Enbrel, which is used to treat inflammatory conditions including rheumatoid arthritis, psoriatic arthritis and plaque ...
- Financial News USA (press release)
FDA Approves Remicade for Treatment of Ulcerative Colitis Sep 16, 2005
...by Centocor, was already approved for the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis, among other ...
- MedPage Today
Cambridge Antibody Technology Appoints John Brown as Non-Executive ... Sep 11, 2005
...with Abbott and has been approved for marketing as a treatment for rheumatoid arthritis (RA) in 58 countries, and for psoriatic arthritis and early RA in some ...
- PR Newswire (press release)
Abbott Bioresearch Center, Genentech, Inc. and ImClone Systems Inc ... Aug 31, 2005
Abbott announced that it has received approval from the European Commission to market HUMIRA® (adalimumab) as a treatment for psoriatic arthritis and early ...
- Yahoo! News (press release)
HEALTH CALENDAR Sep 6, 2005
Dermatology will discuss breakthrough treatments for psoriasis at Saturday's gathering of the Dallas-Fort Worth Psoriasis and Psoriatic Arthritis Support Group ...
- Dallas Morning News (subscription)
Developmental drugs offer new hope for devastating lung disease Aug 31, 2005
...a recombinant human TNF-alpha soluble receptor that is approved to treat rheumatoid arthritis, psoriasis, ankylosing spondylitis and psoriatic arthritis. ...
- Pharmaceutical Business Review
Psoriasis Foundation(R) National Conference Converges in BostonJul 29, 2005
This annual event -- held in a different location each year -- is designed specifically for people affected by psoriasis and psoriatic arthritis, and their ...
- Yahoo News
EUROPEAN UNION CHMP RECOMMENDS APPROVAL OF REMICADE(R) FOR ...Jul 28, 2005
Japan. In the EU and in the US, REMICADE is approved for the treatment of active ankylosing spondylitis (AS) and psoriatic arthritis. ...
- ITNews
Treating RA: Recent Evidence from the European League Against ...Jul 25, 2005
...significance. Two studies were presented on longer-term follow-up of the IMPACT study evaluating infliximab in psoriatic arthritis. ...
- Medscape (subscription)
Psoriasis Cure Now Applauds US Senate for its Strong Commitment to ...Jul 15, 2005
...capital, today applauded the US Senate for including its strongest language ever in support of increased federal research on psoriasis and psoriatic arthritis. ...
- U.S. Newswire
Psoriasis Cure Now makes final push for full coverage of psoriasis ...Jul 24, 2005
...“Older Americans need access to the full range of effective treatments for psoriasis and psoriatic arthritis,� said Michael Paranzino, president of ...
- Medical News Today
Wyeth Reports Earnings Results for the 2005 Second Quarter and ...Jul 20, 2005
...of chronic inflammatory diseases, including rheumatoid arthritis (RA), juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis ...
- Yahoo News
New Treatments Offer Hope for Psoriasis PatientsJul 26, 2005
About 10 percent to 30 percent of psoriasis patients develop psoriatic arthritis, which produces inflammation on or around several joints in the body. ...
- Ivanhoe
Source: Johnson & JohnsonJul 19, 2005
...generalized tonic-clonic seizures and for REMICADE (infliximab) to reduce the signs and symptoms of active arthritis in patients with psoriatic arthritis. ...
- Yahoo News
Schering-Plough Reports Financial Results for 2005 Second QuarterJul 21, 2005
...the United States (excluding Japan and certain Far East markets) for rheumatoid arthritis, early rheumatoid arthritis, psoriatic arthritis, Crohn's disease and ...
- Yahoo News
Amgen Says 2nd-Qtr Profit Rose 38% on Aranesp Sales (Update2)Jul 19, 2005
In addition to psoriasis, Enbrel is approved for a related condition called psoriatic arthritis, which affects a patient's joints and skin. ...
- Bloomberg
Amgen Shares Surge on EarningsJul 20, 2005
...arthritis drug Enbrel, which received recent approval from the Food and Drug Administration for treatment of people with psoriatic arthritis, an inflammatory ...
- Los Angeles Business Journal
Amgen's Stock Surges On Second-Quarter SurpriseJul 20, 2005
...indication for Enbrel. The product now can be marketed to improve physical function in patients with psoriatic arthritis. Amgen also ...
- BioWorld Online (subscription)
Amgen's Second Quarter 2005 Adjusted Earnings Per Share Increased ...Jul 19, 2005
Enbrel: During the quarter, the FDA approved an expanded indication for ENBREL to improve physical function in patients with psoriatic arthritis. ...
- Genetic Engineering News
Instead of pain pills, try hard workJul 5, 2005
...even wrote a letter to the insurer stating that, in his opinion, acupuncture was a medical necessity for treating Harrington's psoriatic arthritis, which tends ...
- Boston Globe
Abbott Reports 17.5 Percent Sales Increase in the Second QuarterJul 13, 2005
...recommending approval of HUMIRA® (adalimumab) for the first-line treatment of moderate to severe early rheumatoid arthritis, as well as psoriatic arthritis. ...
- Yahoo News
Grace of health insuranceJul 6, 2005
I wanted to find a speeding truck and throw myself under it. What I had, according to my rheumatologist, was something called psoriatic arthritis. ...
- Philadelphia Inquirer
Small Leaps or Giant StepsJul 13, 2005
...long before people discovered just how potent it could be in attenuating the course of a bowel ailment known as Crohn’s disease, psoriatic arthritis, and now ...
- American Enterprise Institute
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Psoriatic Arthritis
you may want to try searching the Internet using the Google search box below.
|
|
|
